When it comes to innovation in Silicon Valley, what often gets lost in the noise is the size of its impressive footprint in the life sciences sector.
In fact, in addition to being ranked #1 for technology, Silicon Valley is host to nearly 1,000 biotech companies, and, as part of the broader Bay Area, anchors a massive ecosystem with over 36 million square feet of lab space.
Some of the leading life sciences companies are based here, including Genentech (Roche), Gilead Sciences, Twist Bioscience, 10x Genomics and Guardant Health, among others, with the enterprises focusing on areas ranging from DNA synthesis and genetic diagnostics to oncology and AI-driven drug discovery.
Further, the broader SF Bay Area, including South San Francisco and the Peninsula, continues to lead nationally in VC for life sciences, capturing over 35% of U.S. funding this past year, according to a report by Intuition Labs.
When it comes to AI in particular, we’re increasingly seeing a greater intersection between startups and this important industry.
This week Los-Altos based Prezent AI announced the launch of its Vivo solution to help life sciences companies increase the pace of deliverables with a solution that’s looking to power the entire life sciences communication ecosystem.
A look into Prezent Vivo
Prezent, which is led by Rajat Mishra, was recently valued at $400M and has long built a strong reputation as being a leader when it comes to AI and communications.
In particular, the company has built an impressive business around an AI-powered communications platform that specializes in producing powerful presentations. Working with over 150 life science companies and 45 of the top 50 biopharma companies gave the team at Prezent a front row seat to the wider challenges leaders in the industry have been facing when it comes to scaling AI tools for communication.
This led to the launch of Prezent Vivo, and support the full content lifecycle with a purpose-built AI model and domain experts to support biopharma communications.
Rather than replacing traditional agencies entirely, Vivo supports these teams to meet the goals of biopharma companies to deliver content in a faster turnaround without a loss of quality by setting up a platform that combines the unparalleled speed of AI with the human oversight of domain experts.
“The future of Life Sciences communication is AI and experts, fused into one,” said Rajat Mishra, CEO and Co-Founder of Prezent AI.
The newly launched Vivo platform offers AI-powered communication at speed and scale across the full spectrum of content deliverables. This includes the full product lifecycle that ranges from congress posters, data visualization, scientific documents, brochures, and MSL narrative decks.
“General-purpose AI produces output that looks polished but misses the science, while agencies deliver the scientific gold standard in a model that wasn’t built for today’s pace. And agencies adding AI on top have created another layer of complexity, not a new experience. Prezent Vivo is the only partner built from day one to deliver speed and substance together,” Mishra continued.
22-year MedComms veteran to join team
The Silicon Valley-based company also announced this week that Francine Carrick, a 22-year MedComms veteran, had been appointed as President of Prezent Vivo.
Said the executive in a statement from the company, “I joined Prezent Vivo because I dreamt of a solution that would let the best people in MedComms bring more value to their clients.”
“MedComms is undergoing a real transformation, and the agencies I’ve admired most are the ones asking how to elevate their experts,” added Carrick.
Francine was earlier the Group Managing Director, Medical Communications at BGB Group, and prior to that was Executive Director, Client Strategy and Operations at Envision Pharma Group.
This convergence of tech enterprise and the life sciences looks to be a trend we should increasingly expect more of in Silicon Valley and across the U.S.
For instance, last month AI powerhouse Anthropic announced it was acquiring the biotech startup Coefficient Bio in a $400 million stock deal.
This convergence may occur even faster in the age of AI, where increasingly tech leaders are leaning on one another –and on organizations– to move faster.
Wrote Nate MacLeitch, who founded Healthcare Chatbot by QuickBlox, ‘Too many AI tools still assume you have time, technical resources, or patience to ‘figure things out.’ Most businesses don’t.”
It was in part the pull of these markets in the U.S. that international solutions including Revenue OS by ADvendio, Deep Care, Planno and others have been expanding into the region and country.
Article’s featured photo of Prezent CEO Rajat Mishra
